| Literature DB >> 18250435 |
Angelo A Manfredi1, Annalisa Capobianco, Antonio Esposito, Francesco De Cobelli, Tamara Canu, Antonella Monno, Angela Raucci, Francesca Sanvito, Claudio Doglioni, Peter P Nawroth, Angelika Bierhaus, Marco E Bianchi, Patrizia Rovere-Querini, Alessandro Del Maschio.
Abstract
The mobilization of dendritic cells (DCs) from peripheral tissues is critical for the establishment of T cell-dependent immune responses or tolerance, because the physical interaction of DCs with naive T cells takes place in the T cell areas of lymph nodes. The autocrine/paracrine release of the high mobility group box 1 (HMGB1) nuclear protein by DCs controls the outcome of the DC-T cell interaction, influencing the priming/Th1 polarization of naive T cells. We herein present evidence that the receptor for advanced glycation end products (RAGE), a multiligand member of the Ig superfamily of cell-surface molecules that acts as a receptor for HMGB1, plays a nonredundant role in DC homing to lymph nodes. We used noninvasive imaging by magnetic resonance and immunohistochemistry to track DCs after s.c. injection in the footpad of wild-type(+/+) or RAGE(-/-) mice. Maturing DCs expressing RAGE effectively migrated in both conditions. In contrast, RAGE(-/-) DCs failed to reach the draining popliteal lymph nodes of +/+ and -/- mice, indicating that the integrity of RAGE is required for DC mobilization. Thus the HMGB1-RAGE pathway is a checkpoint in DC maturation and function and a candidate for targeted therapies.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18250435 DOI: 10.4049/jimmunol.180.4.2270
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422